4//SEC Filing
Dowden Nathan J 4
Accession 0001873392-25-000003
CIK 0001689375other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:03 PM ET
Size
5.4 KB
Accession
0001873392-25-000003
Insider Transaction Report
Form 4
Dowden Nathan J
President & COO
Transactions
- Tax Payment
Common Stock
2025-09-02$5.43/sh−1,746$9,481→ 179,059 total
Footnotes (2)
- [F1]This sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of previously granted RSUs.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.36 to $5.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001873392
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 5:03 PM ET
- Size
- 5.4 KB